Shareholders push casinos to reassess indoor smoking

Shareholders push casinos to reassess indoor smoking


A new strategy has emerged in the battle to ban smoking in casinos: the shareholder vote.

Shareholders at Boyd Gaming, Bally’s Entertainment and Caesars Entertainment will put on the ballot at the respective casino companies proposals to force them to study the costs associated with permitting smoking indoors — and whether going smoke-free could save money.

The proposals are sponsored sponsored by Trinity Health, a nonprofit health care network, and the Americans for Nonsmokers’ Rights Foundation. Trinity Health, based in Livonia, Michigan, has used its shareholder status to fight for various health initiatives despite the fact that it owns a tiny fraction of these companies. For example, public records show Trinity owns just 440 shares of Bally’s stock, which represents 0.001% of the company.

All three casino companies fought to keep the proposals out of the proxy materials distributed to shareholders. The Securities and Exchange Commission denied the casinos’ requests, and the proposals as well as the rationale behind them were delivered to all shareholders.

Boyd Gaming will face a vote over a smoke-free assessment at its annual shareholder meeting Thursday. Bally’s holds its annual meeting on May 16, and Caesars will follow with its own meeting, likely in June.

The three companies collectively operate 75 U.S. casinos that permit indoor smoking, where state law allows. Approximately 14 states permit indoor smoking in commercial casinos.

States like Nevada and New Jersey have prohibited indoor smoking more broadly, but carved out exceptions for casinos. Legislation to end indoor smoking at casinos is in various stages in several states across the country, including New Jersey, Pennsylvania and Rhode Island.

Advocates for smoking bans point to research by C3 Gaming that concluded smoke-free casinos generate more revenue and outperform competitors that allow smoking.

Proposal sponsors argue shareholders should know how much casinos pay in higher health insurance premiums for employees, greater maintenance costs and keeping away customers who hate the smoke.

In its proxy, Boyd argues it’s seen a negative impact in states that banned indoor smoking. It argues these decisions are best left up to the properties to follow local trends and says if shareholders succeed in implementing a ban (which Boyd claims is the true goal in forcing an assessment), the company will lose customers to competitors who continue to allow smoking.

Caesars board member Jan Jones Blackhurst said Wednesday at the SBC Summit North America, an online gaming conference, that she believes the decision of whether to ban smoking in casinos should be left up to governments. Still, she acknowledged casinos would take an economic hit if smoking bans were enacted.

“Generally, if you look across the United States, when casinos prohibit smoking, revenues falls anywhere from 20% to 25%, which also then have a huge layoff factor with people starting to lose their jobs,” she said.

Workers unions are mixed on their response. While some worry about the potential of job losses, the United Auto Workers union, which represents more than 10,000 table game dealers across the country, has ramped up its efforts in the fight against in-casino smoking, citing secondhand exposure for employees.

The Centers for Disease Control and Prevention says “no amount of exposure to secondhand smoke is safe and the only way to fully protect nonsmokers from secondhand smoke is through 100% smoke free indoor air environments.”

The U.S. Surgeon General says that many common practices found in casinos such as separating smoking versus non-smoking sections, cleaning the air and ventilating buildings are not effective protections against secondhand smoke.

Casino operator Parx, which runs locations in Pennsylvania, decided to stay smoke-free during the Covid pandemic at its property in Bensalem, North of Philadelphia. It competes with four other local casinos that allow smoking indoors, but said it hasn’t seen its market share suffer.

“Financially, we know we’ve lost some customers, but we also know we’ve gained some customers. We don’t think we’ve seen a significant impact either way,” Parx spokesperson Marc Oppenheimer told CNBC.

Instead the company focuses on its guest satisfaction scores and surveys that indicate a boost to employee morale.

In Las Vegas, MGM Resorts opened the first casino resort on the Strip to prohibit indoor smoking and even smoking on the pool deck. On its website, the property declares, “Here at Park MGM, we’re not afraid to be different and, as you may have noticed, we’re all about what’s fresh. Now, that includes the air you breathe. “

For now, Park MGM is the exception, but smoke-free advocates hope soon, it’ll be the rule.



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More